Equity markets plunge over 1,000 points as fears of US tariffs spark widespread selling, intensifying selloff across sectors.

In addition, he will lean on Fidelity's U.S. real estate securities research team led by Steve Buller, as well as the firm's nearly 200 U.S. and international-equity research analysts, to provide ...

Moat stocks thrived in January, dodging AI-driven tech turmoil with gains in health care and mid-cap standouts. Click to read ...

Ripple's XRP saw a 3% gain on Monday as Bloomberg analysts Eric Balchunas and James Seyffart released a list of the most ...

3Q24 GDP grew 5.3%. CIMB Securities Research, which has maintained GDP growth for this year at 5%, said growth would be reflective of strong domestic spending supported by robust investments and ...

The trends on Gift Nifty indicate a flat-to-positive start for the Indian benchmark index. The Gift Nifty was trading around ...

Day traders can benefit from diverse instrument selection, competitive spreads, and high-quality in-house market research. ACY Securities could improve the offering by providing actionable trading ...

JMP Securities adjusted its price target for Esperion Therapeutics (NASDAQ:ESPR) shares, lowering it to $4.00 from the previous $7.00. Currently trading at $1.86, the stock sits well below analyst ...

according to a new report released today by Cornerstone Research and the Stanford Law School Securities Class Action Clearinghouse. The increase came despite a continued year-over-year decline in ...

Likewise, Solana and XRP ETFs also got approval odds of 70% and 65%, respectively. Notably, only the Litecoin and Solana ETF ...

According to industry sources, the market regulator is are working to ease a few of the guidelines issued in January. Sebi ...